There’s more good news for Abiomed coming into the new year. The Danvers, MA-based company reported successful results of the VENUS-HF Early feasibility study of the precardiac system.
News of the first-in-human feasibility study comes as the company contended with uncertainty caused by the Delta variant and hospital labor shortages throughout 2021.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2025,